About Cellular Dynamics International (NASDAQ:ICEL)
Cellular Dynamics International, Inc. develops and produces functioning human cells in industrial quantities. The Company's products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell products). It markets its products for use in life science in vitro research and development, as well as applied product testing, stem cell banking and in vivo cellular therapeutics. It is also in the process of developing human cells as cellular therapeutics. The market for in vitro drug discovery, toxicity testing and applied testing, including chemical safety, has employed models, such as primary cells, transformed (immortalized) cells and live animals that act as surrogates for functioning human cells. Its iCell and MyCell products consist of iCell Cardiomyocytes, iCell Neurons, iCell DopaNeurons, iCell Endothelial Cells, iCell Hepatocytes, MyCell and Media and reprogramming kit.
Industry, Sector and Symbol
Industry Biotechnology & Medical Research
Trailing P/E Ratio-8.53092783505155
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-57.59%
Return on Assets-38.09%
Cellular Dynamics International (NASDAQ:ICEL) Frequently Asked Questions
What is Cellular Dynamics International's stock symbol?
Cellular Dynamics International trades on the NASDAQ under the ticker symbol "ICEL."
How were Cellular Dynamics International's earnings last quarter?
Cellular Dynamics International Inc (NASDAQ:ICEL) issued its quarterly earnings data on Thursday, March, 5th. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.44) by $0.08. The business earned $6.60 million during the quarter, compared to analysts' expectations of $5 million. Cellular Dynamics International had a negative return on equity of 57.59% and a negative net margin of 88.12%. View Cellular Dynamics International's Earnings History.
Who are some of Cellular Dynamics International's key competitors?
Some companies that are related to Cellular Dynamics International include Puretech Health (PRTC), Protalix Biotherapeutics (PLX), Horizon Discovery Group (HZD), Palatin Technologies (PTN), Silence Therapeutics (SLN), Bioventix (BVXP), Asterias Biotherapeutics (AST), Tissue Regenix Group (TRX), Matinas BioPharma (MTNB), Navidea Biopharmaceuticals (NAVB), NovaBay Pharmaceuticals (NBY), Abzena (ABZA), Scancell (SCLP), Can Fite Biopharma (CANF), ReNeuron Group (RENE), Repros Therapeutics (RPRX), Akers Biosciences (AKR) and AmpliPhi Biosciences (APHB).
Has Cellular Dynamics International been receiving favorable news coverage?
News articles about ICEL stock have trended somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cellular Dynamics International earned a media sentiment score of 0.16 on Accern's scale. They also gave media headlines about the company an impact score of 45.74 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.
How do I buy shares of Cellular Dynamics International?
Shares of ICEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cellular Dynamics International's stock price today?
One share of ICEL stock can currently be purchased for approximately $16.55.
How big of a company is Cellular Dynamics International?
Cellular Dynamics International has a market capitalization of $261.72 million.
How can I contact Cellular Dynamics International?
Cellular Dynamics International's mailing address is 525 Science Dr, MADISON, WI 53711-1082, United States. The company can be reached via phone at +1-608-3105100.
MarketBeat Community Rating for Cellular Dynamics International (ICEL)MarketBeat's community ratings are surveys of what our community members think about Cellular Dynamics International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Cellular Dynamics International (NASDAQ:ICEL) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Cellular Dynamics International (NASDAQ:ICEL) Earnings History and Estimates Chart
Cellular Dynamics International (NASDAQ ICEL) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/5/2015||Q414||($0.44)||($0.36)||$5.00 million||$6.60 million||View||N/A|
|11/10/2014||Q314||($0.49)||($0.52)||$4.00 million||$1.80 million||View||N/A|
|8/11/2014||Q214||($0.48)||($0.54)||$4.62 million||$3.64 million||View||N/A|
|5/5/2014||Q1||($0.34)||($0.52)||$4.66 million||$2.90 million||View||N/A|
|3/10/2014||Q413||($0.30)||($0.43)||$4.27 million||$4.20 million||View||N/A|
|11/12/2013||Q3 2013||($0.33)||($0.62)||$2.90 million||$2.52 million||View||N/A|
|8/29/2013||Q2 13||($2.92)||$2.88 million||$2.81 million||View||N/A|
Cellular Dynamics International (NASDAQ:ICEL) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Cellular Dynamics International (NASDAQ:ICEL)
No dividend announcements for this company have been tracked by MarketBeat.com
Cellular Dynamics International (NASDAQ ICEL) Insider Trading and Institutional Ownership History
Cellular Dynamics International (NASDAQ ICEL) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|7/24/2013||Floor Investors Lp Sixth||Director||Buy||40,000||$12.00||$480,000.00|| |
Cellular Dynamics International (NASDAQ ICEL) News Headlines
Cellular Dynamics International (NASDAQ:ICEL) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Cellular Dynamics International (NASDAQ:ICEL) Income Statement, Balance Sheet and Cash Flow Statement
Cellular Dynamics International (NASDAQ ICEL) Stock Chart for Saturday, March, 24, 2018